Trimtech Therapeutics
biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases
Cambridge, UKtrimtechtherapeutics.com ↗
Total raised
€29M
€28,743,039
Funding rounds
1
Investors
8
distinct backers
Active since
2025-03
latest 2025-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood48
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-05 | Seed | €29M | Cambridge Enterprise Ventures,Cambridge Innovation Capital,Dementia Discovery Fund,Eli lilly and company,M Ventures,MP Healthcare Venture Management+2 more | View deal → |